1-6 of 6
Authors: Keith A A Fox
Save search
Sort by
Journal Article
EDITOR'S CHOICE

Antithrombotic treatment strategies in patients with established coronary atherosclerotic disease

PDF
Marco Valgimigli and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 9, Issue 5, August 2023, Pages 462–496, https://doi.org/10.1093/ehjcvp/pvad032
Published: 29 April 2023
Journal Article
EDITOR'S CHOICE

Within and beyond 12-month efficacy and safety of antithrombotic strategies in patients with established coronary artery disease: two companion network meta-analyses of the 2022 joint clinical consensus statement of the European Association of Percutaneous Cardiovascular Interventions (EAPCI), European Association for Acute CardioVascular Care (ACVC), and European Association of Preventive Cardiology (EAPC)

PDF
Eliano Pio Navarese and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 9, Issue 3, April 2023, Pages 271–290, https://doi.org/10.1093/ehjcvp/pvad016
Published: 03 March 2023
Journal Article

Patients selected for dual pathway inhibition in clinical practice have similar characteristics and outcomes to those included in the COMPASS randomized trial: The XATOA Registry

PDF
Keith A A Fox and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 8, Issue 8, December 2022, Pages 825–836, https://doi.org/10.1093/ehjcvp/pvac028
Published: 20 May 2022
Journal Article

Long-Term Treatment with the Combination of Rivaroxaban and Aspirin in Patients with Chronic Coronary or Peripheral Artery Disease: Outcomes During the Open Label Extension of the COMPASS trial

PDF
John W Eikelboom and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 8, Issue 8, December 2022, Pages 786–795, https://doi.org/10.1093/ehjcvp/pvac023
Published: 06 April 2022
Journal Article

Low-dose rivaroxaban plus aspirin in patients with polypharmacy and multimorbidity: an analysis from the COMPASS trial

PDF
Thomas Vanassche and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 8, Issue 5, September 2022, Pages 462–473, https://doi.org/10.1093/ehjcvp/pvab050
Published: 30 June 2021
Journal Article
EDITOR'S CHOICE

New artificial intelligence prediction model using serial prothrombin time international normalized ratio measurements in atrial fibrillation patients on vitamin K antagonists: GARFIELD-AF

PDF
Shinichi Goto and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 6, Issue 5, September 2020, Pages 301–309, https://doi.org/10.1093/ehjcvp/pvz076
Published: 10 December 2019